These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

261 related items for PubMed ID: 20547804

  • 21. Increased cell wall teichoic acid production and D-alanylation are common phenotypes among daptomycin-resistant methicillin-resistant Staphylococcus aureus (MRSA) clinical isolates.
    Bertsche U, Yang SJ, Kuehner D, Wanner S, Mishra NN, Roth T, Nega M, Schneider A, Mayer C, Grau T, Bayer AS, Weidenmaier C.
    PLoS One; 2013; 8(6):e67398. PubMed ID: 23785522
    [Abstract] [Full Text] [Related]

  • 22. Comparative efficacy of telavancin and daptomycin in experimental endocarditis due to multi-clonotype MRSA strains.
    Xiong YQ, Abdelhady W, Tang C', Bayer AS.
    J Antimicrob Chemother; 2016 Oct; 71(10):2890-4. PubMed ID: 27353467
    [Abstract] [Full Text] [Related]

  • 23. Tedizolid as Step-Down Therapy following Daptomycin versus Continuation of Daptomycin against Enterococci and Methicillin- and Vancomycin-Resistant Staphylococcus aureus in a Rat Endocarditis Model.
    Singh KV, Arias CA, Murray BE.
    Antimicrob Agents Chemother; 2020 Apr 21; 64(5):. PubMed ID: 32122892
    [Abstract] [Full Text] [Related]

  • 24. In vitro cross-resistance to daptomycin and host defense cationic antimicrobial peptides in clinical methicillin-resistant Staphylococcus aureus isolates.
    Mishra NN, McKinnell J, Yeaman MR, Rubio A, Nast CC, Chen L, Kreiswirth BN, Bayer AS.
    Antimicrob Agents Chemother; 2011 Sep 21; 55(9):4012-8. PubMed ID: 21709105
    [Abstract] [Full Text] [Related]

  • 25. VraSR and Virulence Trait Modulation during Daptomycin Resistance in Methicillin-Resistant Staphylococcus aureus Infection.
    Taglialegna A, Varela MC, Rosato RR, Rosato AE.
    mSphere; 2019 Feb 13; 4(1):. PubMed ID: 30760612
    [Abstract] [Full Text] [Related]

  • 26. Impact of High-Level Daptomycin Resistance in the Streptococcus mitis Group on Virulence and Survivability during Daptomycin Treatment in Experimental Infective Endocarditis.
    Garcia-de-la-Maria C, Xiong YQ, Pericas JM, Armero Y, Moreno A, Mishra NN, Rybak MJ, Tran TT, Arias CA, Sullam PM, Bayer AS, Miro JM.
    Antimicrob Agents Chemother; 2017 May 13; 61(5):. PubMed ID: 28264848
    [Abstract] [Full Text] [Related]

  • 27. Phenotypic and genotypic characterization of daptomycin-resistant methicillin-resistant Staphylococcus aureus strains: relative roles of mprF and dlt operons.
    Mishra NN, Bayer AS, Weidenmaier C, Grau T, Wanner S, Stefani S, Cafiso V, Bertuccio T, Yeaman MR, Nast CC, Yang SJ.
    PLoS One; 2014 May 13; 9(9):e107426. PubMed ID: 25226591
    [Abstract] [Full Text] [Related]

  • 28. Bactericidal activity of oxacillin and glycopeptides against Staphylococcus aureus in patients with endocarditis: looking for a relationship between tolerance and outcome.
    Pasticci MB, Moretti A, Stagni G, Ravasio V, Soavi L, Raglio A, Vailati F, Cardaccia A, Santucci A, Papili R, Sgrelli A, Pallotto C, Baldelli F.
    Ann Clin Microbiol Antimicrob; 2011 Jun 09; 10():26. PubMed ID: 21658248
    [Abstract] [Full Text] [Related]

  • 29. Combination of Tedizolid and Daptomycin against Methicillin-Resistant Staphylococcus aureus in an In Vitro Model of Simulated Endocardial Vegetations.
    Smith JR, Yim J, Rice S, Stamper K, Kebriaei R, Rybak MJ.
    Antimicrob Agents Chemother; 2018 May 09; 62(5):. PubMed ID: 29530843
    [Abstract] [Full Text] [Related]

  • 30. Daptomycin is effective in treatment of experimental endocarditis due to methicillin-resistant and glycopeptide-intermediate Staphylococcus aureus.
    Marco F, de la Mària CG, Armero Y, Amat E, Soy D, Moreno A, del Río A, Almela M, Mestres CA, Gatell JM, Jiménez de Anta MT, Miró JM, Hospital Clinic Experimental Endocarditis Study Group.
    Antimicrob Agents Chemother; 2008 Jul 09; 52(7):2538-43. PubMed ID: 18426900
    [Abstract] [Full Text] [Related]

  • 31. Emerging issues on Staphylococcus aureus endocarditis and the role in therapy of daptomycin plus fosfomycin.
    García de la Mària C, Cañas MA, Fernández-Pittol M, Dahl A, García-González J, Hernández-Meneses M, Cuervo G, Moreno A, Miró JM, Marco F.
    Expert Rev Anti Infect Ther; 2023 Mar 09; 21(3):281-293. PubMed ID: 36744387
    [Abstract] [Full Text] [Related]

  • 32. Synergistic activity of ceftobiprole and vancomycin in a rat model of infective endocarditis caused by methicillin-resistant and glycopeptide-intermediate Staphylococcus aureus.
    Fernandez J, Abbanat D, Shang W, He W, Amsler K, Hastings J, Queenan AM, Melton JL, Barron AM, Flamm RK, Lynch AS.
    Antimicrob Agents Chemother; 2012 Mar 09; 56(3):1476-84. PubMed ID: 22232278
    [Abstract] [Full Text] [Related]

  • 33. In vivo acquired daptomycin resistance during treatment of methicillin-resistant Staphylococcus aureus endocarditis.
    Dortet L, Anguel N, Fortineau N, Richard C, Nordmann P.
    Int J Infect Dis; 2013 Nov 09; 17(11):e1076-7. PubMed ID: 23578850
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Prolonged Exposure to β-Lactam Antibiotics Reestablishes Susceptibility of Daptomycin-Nonsusceptible Staphylococcus aureus to Daptomycin.
    Jenson RE, Baines SL, Howden BP, Mishra NN, Farah S, Lew C, Berti AD, Shukla SK, Bayer AS, Rose WE.
    Antimicrob Agents Chemother; 2020 Aug 20; 64(9):. PubMed ID: 32601160
    [Abstract] [Full Text] [Related]

  • 39. High-dose daptomycin plus fosfomycin is safe and effective in treating methicillin-susceptible and methicillin-resistant Staphylococcus aureus endocarditis.
    Miró JM, Entenza JM, Del Río A, Velasco M, Castañeda X, Garcia de la Mària C, Giddey M, Armero Y, Pericàs JM, Cervera C, Mestres CA, Almela M, Falces C, Marco F, Moreillon P, Moreno A, Hospital Clinic Experimental Endocarditis Study Group.
    Antimicrob Agents Chemother; 2012 Aug 20; 56(8):4511-5. PubMed ID: 22644033
    [Abstract] [Full Text] [Related]

  • 40. Daptomycin-β-Lactam Combinations in a Rabbit Model of Daptomycin-Nonsusceptible Methicillin-Resistant Staphylococcus aureus Endocarditis.
    Chambers HF, Basuino L, Hamilton SM, Choo EJ, Moise P.
    Antimicrob Agents Chemother; 2016 Jul 20; 60(7):3976-9. PubMed ID: 27090173
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.